Literature DB >> 3458465

Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex.

R Pircher, P Jullien, D A Lawrence.   

Abstract

Human blood platelets, the richest known source of beta-transforming Growth Factor extractable under acid conditions, release in neutral extracts (pH 7.2) a latent form of this growth factor with an apparent molecular weight of 400 Kd. This latent form, poorly active on rat NRK-49F indicator cells in soft agar assays can be activated by exposure to acid pH or 8 molar urea. The acid activated beta-Transforming Growth Factor from neutral extracts elutes on Biogel P60, in 1 molar acetic acid, as a broad peak of apparent molecular weight 15-30 Kd, like when this factor is extracted from platelets by the usual acid-ethanol procedure. Moreover, beta-Transforming Growth Factor from both acid activated neutral extracts and from acid-ethanol extracts elutes on reverse phase at 30% acetonitrile. We suggest that beta-Transforming Growth Factor is stored in human blood platelets as a poorly active high molecular weight complex which may be dissociated and activated in appropriate in vivo microenvironments.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458465     DOI: 10.1016/0006-291x(86)90872-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

Review 1.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 3.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

4.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

5.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

6.  Exogenous transforming growth factor-beta 2 enhances connective tissue formation and wound strength in guinea pig dermal wounds healing by secondary intent.

Authors:  G A Ksander; Y Ogawa; G H Chu; H McMullin; J S Rosenblatt; J M McPherson
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

7.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.

Authors:  J Pfeilschifter; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Molecular cloning of the large subunit of transforming growth factor type beta masking protein and expression of the mRNA in various rat tissues.

Authors:  T Tsuji; F Okada; K Yamaguchi; T Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

9.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.

Authors:  T B Connor; A B Roberts; M B Sporn; D Danielpour; L L Dart; R G Michels; S de Bustros; C Enger; H Kato; M Lansing
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

10.  Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

Authors:  W E Russell; R J Coffey; A J Ouellette; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.